Kineta Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
- Investors
-
1
Kineta General Information
Description
Kineta Inc is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients' lives. The company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance.
Contact Information
Website
www.kinetabio.comCorporate Office
- 219 Terry Avenue North
- Suite 300
- Seattle, WA 98109
- United States
Corporate Office
- 219 Terry Avenue North
- Suite 300
- Seattle, WA 98109
- United States
Kineta Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 31. Merger/Acquisition | 30-Jun-2025 | Completed | Generating Revenue | |||
| 30. PIPE | 05-Oct-2023 | Completed | Generating Revenue | |||
| 29. PIPE | 25-Apr-2023 | Completed | Generating Revenue | |||
| 28. PIPE | 19-Dec-2022 | Completed | Generating Revenue | |||
| 27. Reverse Merger | 16-Dec-2022 | Completed | Generating Revenue | |||
| 26. Later Stage VC | 25-Feb-2022 | Completed | Generating Revenue | |||
| 25. Later Stage VC | 24-Nov-2021 | Completed | Generating Revenue | |||
| 24. Later Stage VC | 04-Oct-2021 | Completed | Generating Revenue | |||
| 23. Later Stage VC | 05-May-2020 | $7.95M | $82.9M | Completed | Generating Revenue | |
| 22. Debt - PPP | 15-Apr-2020 | $890K | $75M | Completed | Generating Revenue |
Kineta Comparisons
Industry
Financing
Details
Kineta Competitors (48)
One of Kineta’s 48 competitors is Agenus, a Formerly VC-backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Agenus | Formerly VC-backed | Lexington, MA | ||||
| LeonaBio | Formerly VC-backed | Bothell, WA | ||||
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Affimed | Formerly VC-backed | Mannheim, Germany | ||||
| Marengo Therapeutics | Venture Capital-Backed | Cambridge, MA |
Kineta Patents
Kineta Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023107630-A2 | Amino alcohol compounds and uses thereof | Inactive | 08-Dec-2021 | ||
| WO-2023107630-A3 | Amino alcohol compounds and uses thereof | Inactive | 08-Dec-2021 | ||
| WO-2023107547-A2 | Azetidine and spiroazetidine compounds and uses thereof | Inactive | 08-Dec-2021 | ||
| WO-2023107547-A3 | Azetidine and spiroazetidine compounds and uses thereof | Inactive | 08-Dec-2021 | ||
| AU-2022407047-A1 | Bicyclic heteroarenes and methods of their use | Pending | 08-Dec-2021 | C07D519/00 |
Kineta Signals
Kineta Former Investors (27)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| American Research Capital | Corporation | Minority | ||
| AngelMD | Angel Group | Minority | ||
| Cantilever Investors | Venture Capital | Minority | ||
| Growth and Value Development Inc. | Venture Capital | Minority | ||
| Humedix | Corporation | Minority |
Kineta Acquisitions (1)
Kineta’s most recent deal was a Merger/Acquisition with Yumanity Therapeutics. The deal was made on 16-Dec-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Yumanity Therapeutics | 16-Dec-2022 | Merger/Acquisition | Drug Discovery |
Kineta ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Kineta FAQs
-
When was Kineta founded?
Kineta was founded in 2006.
-
Where is Kineta headquartered?
Kineta is headquartered in Seattle, WA.
-
What is the size of Kineta?
Kineta has 4 total employees.
-
What industry is Kineta in?
Kineta’s primary industry is Drug Discovery.
-
Is Kineta a private or public company?
Kineta is a Private company.
-
What is Kineta’s current revenue?
The current revenue for Kineta is .
-
How much funding has Kineta raised over time?
Kineta has raised $138M.
-
Who are Kineta’s investors?
American Research Capital, AngelMD, Cantilever Investors, Growth and Value Development Inc., and Humedix are 5 of 27 investors who have invested in Kineta.
-
Who are Kineta’s competitors?
Agenus, LeonaBio, CytomX Therapeutics, Affimed, and Marengo Therapeutics are some of the 48 competitors of Kineta.
-
When was Kineta acquired?
Kineta was acquired on 30-Jun-2025.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process